Inflammatory Disease Is Linked to Risk of Deadly Heart Attacks everydayhealth.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from everydayhealth.com Daily Mail and Mail on Sunday newspapers.
Published: Dec 18, 2020 By Alex Keown
Cidara Therapeutics – Christopher Kurtz was named executive vice president of Technical Operations at Cidara Therapeutics. Kurtz brings more than 26 years of experience in global manufacturing, engineering, supply chain, CMC development and program management for drugs and devices at various stages of development. Prior to joining Cidara, Kurtz served as head of commercial API manufacturing at Gilead Sciences. He previously served as vice president, for drug device industrialization at AbbVie, where he led product scale-up and industrialization projects for drug-device combinations. Prior to that, Kurtz held a number of leadership positions at various companies, including Monsanto, Nektar Therapeutics, Alza Corporation, Alexza and Novo Nordisk.
If you’ve recently been diagnosed with rheumatoid arthritis (RA), you’ve probably got questions. Answering the basic ones is easy. But a lot of what we know about this painful inflammatory condition changes almost daily. Even the most veteran practitioners are constantly discovering unexpected aspects of the disease. We asked some of the top rheumatologists in the country to share the surprising things they’ve discovered in treating patients with RA the good… and the not-so-good. This is what they told us.
iStock
RA Is Years in the Making
Even though joint pain is probably what drove you to see your doctor where you were diagnosed with RA it’s possible you had the disease for a long time before realizing it, according to Cornelia M. Weyand, M.D., Ph.D., a professor of medicine at Stanford University’s School of Medicine in California. “It has become clear that the disease process of rheumatoid arthritis starts years or even decades before the patients seek help for